Park Ha Biological Technology Co., Ltd.
BYAH · XNASCIK 1986247fmd_0BTZRQBWWS9CE45432RYJQY3EWManufacturing · Soap, Detergents, Cleang Preparations, Perfumes, CosmeticsTemplate: Standard
Coverage: Nov 01, 2021 to Oct 31, 2025, 6 periods
Latest annual · FY2025
Millions- Total revenues
- 3
- Gross profit
- 2
- Operating income
- (24)
- Net income
- (24)
- Free cash flow
- (0)
Daily close · BYAHIEX trades only
Nov 09, 2026 to Nov 11, 2026 · 3 sessions1.53 USD
Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- +9.6%
Park Ha Biological Technology Co., Ltd. (BYAH) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $2.5 million | $2.4 million | +6% | 20-F 2026-03-02 · proof |
| Gross profit | $2.4 million | $2.2 million | +9% | 20-F 2026-03-02 · proof |
| Operating income | -$24.1 million | $793,714 | -3,142.5% | 20-F 2026-03-02 · proof |
| Net income | -$24.4 million | $478,561 | -5,191.3% | 20-F 2026-03-02 · proof |
| Cash from operating activities | $85,852 | $960,470 | -91.1% | 20-F 2026-03-02 · proof |
| Free cash flow | -$2,973 | $874,901 | -100.3% | 20-F 2026-03-02 · proof |
| Total assets | $6 million | $3.1 million | +93.1% | 20-F 2026-03-02 · proof |
| Total liabilities | $2 million | $1.6 million | +24.1% | 20-F 2026-03-02 · proof |
| Cash and cash equivalents | $3.8 million | $547,498 | +591.8% | 20-F 2026-03-02 · proof |
- What was Park Ha Biological Technology Co., Ltd. (BYAH)'s revenue in fiscal 2025?
- Park Ha Biological Technology Co., Ltd. (BYAH) reported revenue of $2.5 million for fiscal 2025 (the year ended Oct 31, 2025), against $2.4 million the year before (+6%). Source: the 20-F filed with the SEC on Mar 2, 2026. SEC
- What was Park Ha Biological Technology Co., Ltd. (BYAH)'s gross profit in fiscal 2025?
- Park Ha Biological Technology Co., Ltd. (BYAH) reported gross profit of $2.4 million for fiscal 2025 (the year ended Oct 31, 2025), against $2.2 million the year before (+9%). Source: the 20-F filed with the SEC on Mar 2, 2026. SEC
- What was Park Ha Biological Technology Co., Ltd. (BYAH)'s operating income in fiscal 2025?
- Park Ha Biological Technology Co., Ltd. (BYAH) reported operating income of -$24.1 million for fiscal 2025 (the year ended Oct 31, 2025), against $793,714 the year before (-3,142.5%). Source: the 20-F filed with the SEC on Mar 2, 2026. SEC
- What was Park Ha Biological Technology Co., Ltd. (BYAH)'s net income in fiscal 2025?
- Park Ha Biological Technology Co., Ltd. (BYAH) reported net income of -$24.4 million for fiscal 2025 (the year ended Oct 31, 2025), against $478,561 the year before (-5,191.3%). Source: the 20-F filed with the SEC on Mar 2, 2026. SEC
- What was Park Ha Biological Technology Co., Ltd. (BYAH)'s cash from operating activities in fiscal 2025?
- Park Ha Biological Technology Co., Ltd. (BYAH) reported cash from operating activities of $85,852 for fiscal 2025 (the year ended Oct 31, 2025), against $960,470 the year before (-91.1%). Source: the 20-F filed with the SEC on Mar 2, 2026. SEC
- What was Park Ha Biological Technology Co., Ltd. (BYAH)'s free cash flow in fiscal 2025?
- Park Ha Biological Technology Co., Ltd. (BYAH) reported free cash flow of -$2,973 for fiscal 2025 (the year ended Oct 31, 2025), against $874,901 the year before (-100.3%). Source: the 20-F filed with the SEC on Mar 2, 2026. SEC
- What are Park Ha Biological Technology Co., Ltd. (BYAH)'s total assets?
- As of Oct 31, 2025, Park Ha Biological Technology Co., Ltd. (BYAH) reported total assets of $6 million, against $3.1 million a year earlier (+93.1%). Source: the 20-F filed with the SEC on Mar 2, 2026. SEC
- What are Park Ha Biological Technology Co., Ltd. (BYAH)'s total liabilities?
- As of Oct 31, 2025, Park Ha Biological Technology Co., Ltd. (BYAH) reported total liabilities of $2 million, against $1.6 million a year earlier (+24.1%). Source: the 20-F filed with the SEC on Mar 2, 2026. SEC
- What are Park Ha Biological Technology Co., Ltd. (BYAH)'s cash and cash equivalents?
- As of Oct 31, 2025, Park Ha Biological Technology Co., Ltd. (BYAH) reported cash and cash equivalents of $3.8 million, against $547,498 a year earlier (+591.8%). Source: the 20-F filed with the SEC on Mar 2, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:BYAH&period_type=annual&limit=5"Information only, not investment advice.